Alnylam Pharmaceuticals ALNY has outperformed the market over the past 10 years by 3.04% on an annualized basis producing an average annual return of 15.62%. Currently, Alnylam Pharmaceuticals has a market capitalization of $58.59 billion.

Investors need to pay close attention to Alnylam Pharmaceuticals stock based on the movements in the options market lately.

Alnylam Pharmaceuticals ALNY has outperformed the market over the past 15 years by 13.35% on an annualized basis producing an average annual return of 25.78%. Currently, Alnylam Pharmaceuticals has a market capitalization of $57.85 billion.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.